Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
186M
-
Number of holders
-
71
-
Total 13F shares, excl. options
-
46.9M
-
Shares change
-
+46.9M
-
Total reported value, excl. options
-
$1.03B
-
Value change
-
+$1.02B
-
Number of buys
-
70
-
Price
-
$21.91
Significant Holders of Revolution Medicines, Inc. - Common Stock (RVMD) as of Q1 2020
71 filings reported holding RVMD - Revolution Medicines, Inc. - Common Stock as of Q1 2020.
Revolution Medicines, Inc. - Common Stock (RVMD) has 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.9M shares
of 186M outstanding shares and own 25.23% of the company stock.
Largest 10 shareholders include TRV GP III, LLC (9.02M shares), Svennilson Peter (7.98M shares), FMR LLC (6.66M shares), BOXER CAPITAL, LLC (3.05M shares), Cormorant Asset Management, LP (2.77M shares), TRV GP II, LLC (1.91M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.8M shares), TRV GP IV, LLC (1.42M shares), BVF INC/IL (1.4M shares), and Casdin Capital, LLC (1.32M shares).
This table shows the top 71 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.